NextCure, Inc. (NXTC) vs Rein Therapeutics Inc. (RNTX)
A side-by-side comparison of NextCure, Inc. and Rein Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
NXTC
NextCure, Inc.
$5.69HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
RNTX
Rein Therapeutics Inc.
$0.83HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — NXTC vs RNTX
growth of $100 · dividends reinvested · last 2yNXTC -61.0% (-37.6%/yr)RNTX -61.1% (-37.6%/yr)NXTC compounded faster over this window
NXTC RNTX
NXTC vs RNTX: by the numbers
- •RNTX is the larger company ($23M vs $21M market cap).
Metrics side by side
Valuation
| Metric | NXTC | RNTX |
|---|---|---|
| P/B ratio | 1.69 | 2.26 |
Profitability
| Metric | NXTC | RNTX |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -351.86% | -487.90% |
| ROIC | -259.91% | -36.89% |
Growth (annualized)
| Metric | NXTC | RNTX |
|---|---|---|
| Total return CAGR (5Y) | -44.29% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.